PT - JOURNAL ARTICLE AU - Shao, Nian AU - Cheng, Jin AU - Chen, Wenbin TI - The reproductive number <em>R</em><sub>0</sub> of COVID-19 based on estimate of a statistical time delay dynamical system AID - 10.1101/2020.02.17.20023747 DP - 2020 Jan 01 TA - medRxiv PG - 2020.02.17.20023747 4099 - http://medrxiv.org/content/early/2020/02/20/2020.02.17.20023747.1.short 4100 - http://medrxiv.org/content/early/2020/02/20/2020.02.17.20023747.1.full AB - In this paper, we estimate the reproductive number R0 of COVID-19 based on Wallinga and Lipsitch framework [11] and a novel statistical time delay dynamic system. We use the observed data reported in CCDC’s paper to estimate distribution of the generation interval of the infection and apply the simulation results from the time delay dynamic system as well as released data from CCDC to fit the growth rate. The conclusion is: Based our Fudan-CCDC model, the growth rate r of COVID-19 is almost in [0.30, 0.32] which is larger than the growth rate 0.1 estimated by CCDC [9], and the reproductive number R0 of COVID-19 is estimated by 3.25 ≤ R0 ≤ 3.4 if we simply use R = 1 + r ∗ Tc with Tc = 7.5, which is bigger than that of SARS. Some evolutions and predictions are listed.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWenbin Chen was supported in part by the National Science Foundation of China (11671098, 91630309) and 111 project(B08018), Jin Cheng was supported in part by the National Science Foundation of China (11971121)Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesthe data is from the annocements of Chinese Center for Disease Control and Prevention, and published papers.